Josh Ney counsels life science companies in patent procurement, freedom to operate, due diligence and litigation matters.
With Ph.D. in chemistry, Josh leverages his technical background to counsel clients on patent matters in a range of technology areas, including small molecule drugs, monoclonal antibodies, mRNA therapeutics, lipid nanoparticles, vaccines, CAR-T therapies, flow cytometry technology and polymer chemistry.
Josh’s patent procurement practice includes patent drafting, prosecution, and worldwide portfolio management in the life sciences industry, including for pharmaceutical products in ongoing Phase 3 clinical trials. He also provides freedom to operate analyses and opinions, due diligence and patent portfolio reviews.
Josh also represents pharmaceutical and biotechnology companies in patent litigation matters and pre-litigation due diligence. His litigation experience includes pharmaceutical litigation under the Hatch-Waxman Act on behalf of both innovator and generic pharmaceutical companies.
Professional and Community Involvement
Vice chair, American Intellectual Property Law Association (AIPLA), Biotechnology Committee
Member, Michigan Drug Discovery External Advisory Board
Member, Michigan Intellectual Property American Inn of Court
Michigan Lawyers Weekly, Up & Coming Lawyers, 2018
Michigan Super Lawyers, Rising Star, 2015-2018
DBusiness magazine, Top Young Lawyer, 2014
Managing Intellectual Property magazine, IP Star, 2013, 2014, 2016-2017